At What Age Could Screening for Familial Retinoblastoma Be Discontinued? A Systematic Review.
age at diagnosis
familial retinoblastoma
screening
Journal
Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829
Informations de publication
Date de publication:
17 Apr 2021
17 Apr 2021
Historique:
received:
26
02
2021
revised:
09
04
2021
accepted:
14
04
2021
entrez:
30
4
2021
pubmed:
1
5
2021
medline:
1
5
2021
Statut:
epublish
Résumé
The aim of this systematic review is to assess the latest age at diagnosis for detection of familial retinoblastoma in order to evaluate at what age screening of at-risk children could be discontinued. Extended screening beyond this age would result in unnecessary patient burden and costs. However, discontinuing screening prematurely would have the adverse effect of missing tumors. We performed a literature search (PubMed, Embase, CINAHL and the Cochrane Library) up until February of 2021 and systematically included studies where patients had a family history of retinoblastoma, a known age at diagnosis, and who were ophthalmologically screened for retinoblastoma from birth. A total of 176 familial retinoblastoma patients from 17 studies were included in this review. Based on 48 months of age being the latest age of diagnosis, ophthalmological screening for familial retinoblastoma could safely be discontinued at age four years.
Identifiants
pubmed: 33920538
pii: cancers13081942
doi: 10.3390/cancers13081942
pmc: PMC8072927
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
Prenat Diagn. 2015 Feb;35(2):174-8
pubmed: 25284592
Br J Ophthalmol. 2006 Jul;90(7):875-8
pubmed: 16613925
Ophthalmic Genet. 2018 Jun;39(3):410-413
pubmed: 29336617
Nat Rev Dis Primers. 2015 Aug 27;1:15021
pubmed: 27189421
Int J Retina Vitreous. 2017 Nov 13;3:43
pubmed: 29158915
Prog Retin Eye Res. 2019 Nov;73:100764
pubmed: 31173880
Am J Hum Genet. 1996 Aug;59(2):301-7
pubmed: 8755916
Cancer. 1991 Feb 1;67(3):710-5
pubmed: 1985763
Ophthalmology. 2016 Dec;123(12):2610-2617
pubmed: 27712844
Pediatr Blood Cancer. 2009 Sep;53(3):338-42
pubmed: 19434730
Oman J Ophthalmol. 2019 Oct 11;12(3):156-159
pubmed: 31902989
Retina. 2019 Jul;39(7):1326-1332
pubmed: 29470311
Am J Ophthalmol. 2000 Mar;129(3):396-8
pubmed: 10704567
Ophthalmology. 2018 Mar;125(3):453-458
pubmed: 29056300
Ophthalmologica. 1993;207(2):106-11
pubmed: 7903808
Arch Ophthalmol. 1982 Aug;100(8):1249-52
pubmed: 7103808
Acta Ophthalmol Scand. 1998 Jun;76(3):334-8
pubmed: 9686848
J AAPOS. 2009 Dec;13(6):546-50
pubmed: 20006813
J Clin Epidemiol. 2009 Oct;62(10):e1-34
pubmed: 19631507
Arch Ophthalmol. 1981 Oct;99(10):1761-2
pubmed: 7295122
Indian J Ophthalmol. 2015 Sep;63(9):741-2
pubmed: 26632134
J Pediatr Ophthalmol. 1976 Sep-Oct;13(5):278-82
pubmed: 1018213
Ophthalmic Genet. 2016 Dec;37(4):430-433
pubmed: 26914665
Am J Ophthalmol. 2021 Mar;223:184-192
pubmed: 33049241
Eye (Lond). 2011 Dec;25(12):1555-61
pubmed: 21921957
Br J Ophthalmol. 2000 Oct;84(10):1170-2
pubmed: 11004105